New Mexico has reached a $2.25 million settlement with EpiPen maker Mylan Inc. over allegations the company used ...
A new settlement between New Mexico and the maker of EpiPen is expected to make the EpiPen more accessible and affordable in ...
In addition to a $2.25 million monetary settlement, the company will donate thousands of EpiPens to the state annually for ...
Teva Pharmaceutical must face a lawsuit claiming it used unlawful methods to block generic competition for its multiple ...
New Mexico Attorney General Raúl Torrez announced that the State of New Mexico has reached a $2.25 million settlement with ...
Mylan has spent more than $460 million buying Novartis cystic fibrosis products. Now, it wants the plant that makes them. Mylan took an option on a Novartis plant in San Carlos, California, when it ...
Mylan investors sent shares reeling after the generics giant reported poor first-quarter numbers. But to hear some analysts tell it, shareholders have far more to worry about: Executives aren't ...
PITTSBURGH (KDKA/AP) -- Pfizer is buying Mylan in an all-stock deal and combining the $10 billion generic pharmaceutical company with its own off-patent branded and generic business. The Pfizer ...
Pharmaceutical firm Mylan is dramatically expanding a nationwide recall of some blood pressure medications after detecting trace amounts of a chemical linked to cancer. The recalled products all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results